Sign in
4

Changes in Ownership

Starling Oncology, Inc. Filed Acc 0001104659-21-140220

Director acquired 30,000 shares (conversion)

  • Director returned 4,466 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Kaushal Mohit · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Owned after D/I
2021-11-12 Conversion : show line 1 in the form +30,000 30,000 D
2021-11-12 Returned to the company : show line 2 in the form −4,466 25,534 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-11-12 Conversion : show line 3 in the form Class B Common Stock −30,000 0 D
Loading xslF345X03/tm2132979-14_4seq1.xml…